ACM Biolabs
PrivateLast Round
Grant
May 8, 2025
Total Funding Raised
$8.55M
Company Overview
ACM Biolabs is a biotechnology company that develops targeted vaccines and immunotherapies using its proprietary polymer-lipid hybrid nanoparticle delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ACM Biolabs Comparables
Compare ACM Biolabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mana.bio | 82% | |
| 20Med Therapeutics | 81% | |
| Genevant Sciences | 81% |
ACM Biolabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 8, 2025 | ||||
| Grant | Apr 22, 2025 | ||||
| Series A | Aug 12, 2021 | ||||
| Seed | Mar 1, 2020 | ||||
| Grant | Jan 20, 2014 |
ACM Biolabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup SG | Grant |
| CEPI | Grant |
| Ritz Venture Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors increased 42% MoM.
- May 8, 2025
$2.87M grant round led by CEPI
ACM Biolabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ACM Biolabs's valuation, stock price, and market status.
Is ACM Biolabs a public or private company?
ACM Biolabs is a private company.
What is the current stock price of ACM Biolabs?
ACM Biolabs is a private company with no public stock price. No recent secondary market data is available.
How much is ACM Biolabs worth (valuation)?
Valuation information for ACM Biolabs is not publicly available.
Can I buy ACM Biolabs stock?
ACM Biolabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ACM Biolabs's last funding round?
ACM Biolabs's most recent funding round was Grant on May 8, 2025.
Who are the main investors in ACM Biolabs?
Key investors in ACM Biolabs include CEPI, Ritz Venture Capital.
Will ACM Biolabs IPO soon?
No public IPO plans have been announced for ACM Biolabs.
How can I track ACM Biolabs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ACM Biolabs's secondary market activity and sign up for updates.